Biotech ClusterFull house at European Cluster ConferenceMore than 900 experts from clusters and the EU Commission discussed at the sold-out 9th European Cluster Conference what cluster policy is needed to make Europe a world leader in prioritised technology … more ➔
biomanufacturingDanish 21st.BIO A/S opens multipurpose pro...Danish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma. more ➔
ImmunologyProtein flags Car-T cells for digestion by...Flagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report. more ➔
BioeconomyBiotalys starts field testing for biofungi...Belgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program. more ➔
OphthalmologyThree companies launch gene therapy allian...AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies. more ➔
ObesityObesity: reseachers switch on brown fat ce...A German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes. more ➔
Clinical trialsKlineo raises €2m to speed up access to...Paris-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.` more ➔
financingLocate Bio Ltd raises £9.2m venture capit...University Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before. more ➔
BiomanufacturingElectrochaea sells biomethane reactor to A...Archaeal Power-to-biomethan producer Electrochaea GmbH has sold a BioCat bioreactor to the Danish CCU specialist Again A/S. more ➔
financingFlindr Therapeutics BV secures €20m Seri...Oss-based oncology company Flindr Therapeutics BV has secured €20m to advance it first-in-class RNF31 inhibitors, which destabilises E3 ubiquitin ligase. more ➔
